Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

2(40%)

Results Posted

100%(3 trials)

Phase Distribution

Ph not_applicable

60%

Ph phase_3

20%

Ph phase_1

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

1(20.0%)

Phase 3Large-scale testing

1(20.0%)

N/ANon-phased studies

3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(3)

Detailed Status

Completed3

Active, not recruiting1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 11 (20.0%)

Phase 31 (20.0%)

N/A3 (60.0%)

Trials by Status

active_not_recruiting120%

completed360%

recruiting120%

Recent Activity

2 active trials

Showing 5 of 5

recruitingnot_applicable

A Study of the Use of Microneedle Patches to Deliver Topical Lidocaine in the Oral Cavity

NCT03629041

Clinical Trials (5)

Showing 5 of 5 trials

NCT07534865Not Applicable

Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts

Recruiting

NCT06293755Phase 3

Microneedle Patch With Botulinum Toxin in Management of Enlarged Facial Pores

Active Not Recruiting

NCT03332628Not Applicable

Racial/Ethnic Differences in Microneedle Response

Completed

NCT02682056Not Applicable

Glucose Measurement Using Microneedle Patches

Completed

NCT03629041Phase 1

A Study of the Use of Microneedle Patches to Deliver Topical Lidocaine in the Oral Cavity

Completed

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5